Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year […]

Leave a Reply

Your email address will not be published.

Previous post KB Home (NYSE:KBH) Price Target Raised to $70.00
Next post Nu Holdings Ltd. (NYSE:NU) Given Consensus Recommendation of “Moderate Buy” by Brokerages